The present disclosure relates to a process of identification of bioactives that inhibit melanin synthesis. The disclosure specifically relates to assaying for up-regulation of microRNAs implicated in negative regulation in genes involved in melanogenesis. The disclosure also provides compositions comprising microRNA(s) that inhibit proteins involved in melanin synthesis.